Vergleich

Recombinant Human IgSF11 (N-Terminal) Protein

ArtNr 230-30108-50
Hersteller Raybiotech
Menge 50 ug
Quantity options 10 ug 200 ug 50 ug
Kategorie
Typ Proteins Recombinant
Format Lyophilized
Applikationen WB, IP, ELISA, Dot
Specific against Human (Homo sapiens)
Host HEK293 cells
Konjugat/Tag HIS
Purity >95%
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Versandbedingung Raumtemperatur
Lieferbar
Manufacturer - Applications
Protein-protein Interaction, Post-translational Modifications, ELISA, EIA, Western Blotting, Dot Blotting, Immunoprecipitation, Protein Array, etc.
Manufacturer - Category
Proteins|Recombinant Proteins|Human Proteins
Manufacturer - Conjugate / Tag
N-terminal histidine tag
Shipping Temperature
Ambient temperature
Storage Conditions
-20°C
Molecular Weight
Recombinant human IgSF11 protein has a calculated molecular mass of 24 kDa. Due to the abundant glycosylation, it migrates as approximately 30-35 kDa protein band in SDS-PAGE under DTT, beta-mercaptoethanol reducing conditions.
Description
Recombinant human immunoglobulin superfamily, member 11, derived from transfected human HEK293 cells.
Purity determined by
SDS-PAGE under reducing conditions and visualized by Coomassie blue staining
Gene Symbols
IGSF11
UNSPSC Code
12352202
Formulation
Lyophilized from a 0.2 µm filtered solution in PBS
Expressed Region
Ala20-Gly244
Protein Name & Synonyms
IgSF11, N-terminal, Immunoglobulin Superfamily, Member 11, Brain And Testis-Specific Immunoglobulin Superfamily Protein, V-Set And Immunoglobulin Domain-Containing Protein 3, Cancer/Testis Antigen 119, BT-IgSF, CXADRL1, VSIG3, V-Set And Immunoglobulin Domain Containing 3, CXADR Like 1, IgSF13, BTIGSF, IgSF11, CT119
Format
Lyophilized powder
Purification
His-tag affinity purification by immobilized metal ion affinity chromatography (IMAC)
Concentration
Determined by Pierce BCA protein assay kit
Reconstitution
Briefly spin the vial and bring the contents to the bottom prior to opening. It is recommended to reconstitute at 0.5 - 1.0 mg/mL with sterile deionized water.
SDS-PAGE Image
Figure 1. Deglycosylation of purified recombinant proteins. Purified proteins were untreated (Lane 2) or treated with Protein Deglycosylation Kit under native (Lane 3) or reducing (Lane 4) conditions. Deglycosylation treatment resulted in a mobility shift of the protein to produce one major band at the expected size, thus indicating that the untreated recombinant protein (Lane 2) was glycosylated. Lane 1: Protein standard ladder (kDa) Lane 2: Untreated protein under reducing conditions Lane 3: Treated protein with deglycosylation enzymes under native conditions Lane 4: Treated protein with deglycosylation enzymes under reducing conditions.Lane 5: Deglycosylation mixture only without target proteins.
Custom Labeling Request
We can custom label this protein with biotin or fluorescent dyes (choose from violet, blue, green or red). Request now.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 50 ug
Lieferbar: In stock
lieferbar

Lieferung vsl. bis 16.10.2025 

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen